Effects of the dual peroxisome proliferator-activated receptor-α/γ agonist aleglitazar on renal function in patients with stage 3 chronic kidney disease and type 2 diabetes: a Phase IIb, randomized…

Overview of attention for article published in BMC Nephrology, November 2014

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (82nd percentile)
High Attention Score compared to outputs of the same age and source (86th percentile)

So far, Altmetric has seen 1 X post from an account with 486 followers.

Effects of the dual peroxisome proliferator-activated receptor-alpha/gamma agonist aleglitazar on renal function... http://t.co/RRvoVWOoZb

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.